Top View
- Therapeutic Class Overview Urinary Antispasmodics
- Overactive Bladder
- A Straightforward Route to Enantiopure Pyrrolizidines And
- In Vivo Quantitative Autoradiographic Analysis of Brain Muscarinic Receptor Occupancy by Antimuscarinic Agents for Overactive Bladder Treatment
- Geriatric Care Otolaryngology © 2006 Head and Neck Surgery Foundation and Neck Head Surgery Academyamerican of Otolaryngology—
- Chirality & Bioactivity I.: Pharmacology, Leffingwell Reports, Vol. 3
- 157 Noninvasive Evaluation of Brain Muscarinic Receptor Occupancy of Imidafenacin, Darifenacin and Oxybutynin in Rats by Positro
- DITROPAN XL (Oxybutynin Chloride)
- Management of Incontinence in Older Adults*
- Antihistamine Prior Authorization Review
- 3703-3712-Flavoxate in the Symptomatic Treatment of Overactive Bladder: a Meta-Analysis
- 209241Orig1s000
- An Approach to Drug Induced Delirium in the Elderly K Alagiakrishnan, C a Wiens
- Ditropan Xl®
- Inhibition of Airway Hyperreactivity by Oxybutynin Chloride in Subjects with Cervical Spinal Cord Injury
- Potentially Harmful Drugs in the Elderly: Beers List and More
- Summary of Product Characteristics
- Oxybutynin Hydrochloride 2.5Mg Tablets
- Diphenhydramine (E.G., Benadryl)
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Apo-Oxybutynin, Syrup
- Newer Agents for the Management of Overactive Bladder BENJAMIN J
- Intravesical Instillation of Oxybutynin Hydrochloride Therapy for Patients
- Medications and Dysphagia Swallowing Risks
- Overactive Bladder Agents
- Anticholinergic Drugs and Dementia
- (12) United States Patent (10) Patent No.: US 6,482,837 B1 Wood (45) Date of Patent: Nov
- Drug Repurposing to Treat Glucocorticoid Resistance in Asthma Alberta L
- Apo-Oxybutynin Oxybutynin Hydrochloride 5Mg Tablets and 5Mg/5Ml Syrup
- (12) United States Patent (10) Patent No.: US 8.481,518 B2 Wood (45) Date of Patent: Jul
- CLASS a MEDICATIONS CLASS B MEDICATIONS the Recovering
- JPET #130021 1 Actions of Two Main Metabolites of Propiverine (M-1 And
- The Toxicology Investigators Consortium Case Registry—The 2011 Experience
- Characterization of Bladder Selectivity of Antimuscarinic Agents on the Basis of in Vivo Drug-Receptor Binding
- Muscarinic Receptor Antagonists, the Overactive Bladder and Efficacy Against Urinary Urgency
- View Library
- Incapacitating Agents
- Package Leaflet: Information for the User Oxybutynin Hydrochloride 2.5Mg/5Ml Oral Solution
- Oxybutynin Misuse
- The Development of Transdermal Ketamine Patch Rie Kubota1, Yoshimichi Maruyama1, Yoshio Wada1, Ayuko Okamoto1, Aya Tsukamoto1, Takako Komiyama1
- TITLE: Oxybutynin, Tolterodine, and Darifenacin: Review of Cognitive Adverse Events
- 79 in Vivo Analysis of Brain Muscarinic Receptor
- Toronto Forensic
- Anticholinergic Drugs for Urinary Incontinence
- Topical Analgesia
- Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
- Oxybutynin and Tolterodine for Treatment of Neurogenic Detrusor Overactivity: a Pharmacoeconomic Evaluation in the Brazilian Context
- That the Tout Untuk Ta in an Area Maria Mai Mari Chanthi
- Anticholinergic Medications and Cognition in Older Adults
- Impact of Anticholinergics on the Aging Brain: a Review and Practical Application
- Neuro-Ophthalmologic Side-Effects of Systemic Medications
- Rationale for the Use of Anticholinergic Agents in Overactive Bladder with Regard to Central Nervous System and Cardiovascular System Side Effects
- Prevent Drug-Drug Interactions with Cholinesterase Inhibitors
- Kentera, INN-Oxybutynin
- Package Leaflet: Information for the User Oxybutynin STADA 5 Mg